{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:50:46Z","timestamp":1791827446844,"version":"4.3.4"},"reference-count":144,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.blre.2006.01.003","type":"journal-article","created":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T13:48:09Z","timestamp":1142344089000},"page":"245-266","source":"Crossref","is-referenced-by-count":95,"title":["Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome"],"prefix":"10.1016","volume":"20","author":[{"given":"Eric J.","family":"Burks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Thomas P.","family":"Loughran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2006.01.003_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V82.1.1.bloodjournal8211","article-title":"Clonal diseases of large granular lymphocytes","volume":"82","author":"Loughran","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-102-2-169","article-title":"Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia","volume":"102","author":"Loughran","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2006.01.003_bib3","series-title":"Clinical Hematology","first-page":"216","article-title":"Large Granular Lymphocyte Leukemia","author":"Burks","year":"2006"},{"key":"10.1016\/j.blre.2006.01.003_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/107327489800500103","article-title":"Large Granular Lymphocyte Leukemia","volume":"5","author":"Lamy","year":"1998","journal-title":"Cancer Control"},{"key":"10.1016\/j.blre.2006.01.003_bib5","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/1097-0142(19871215)60:12<2971::AID-CNCR2820601220>3.0.CO;2-O","article-title":"The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions","volume":"60","author":"Semenzato","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2006.01.003_bib6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.V89.1.256","article-title":"The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis","volume":"89","author":"Semenzato","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib7","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1053\/hupa.2000.19298","article-title":"Utility of immunohistochemistry in bone marrow evaluation of T-lineage large granular lymphocyte leukemia","volume":"31","author":"Evans","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.blre.2006.01.003_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V99.1.268","article-title":"Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B","volume":"99","author":"Morice","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib9","first-page":"16","article-title":"Chronic arthritis in the adult associated with splenomegaly and leukopenia: A report of five cases of an unusual clinical syndrome","volume":"35","author":"Felty","year":"1924","journal-title":"Bulletin of the Johns Hopkins Hospital"},{"key":"10.1016\/j.blre.2006.01.003_bib10","first-page":"156","article-title":"Felty\u2019s syndrome: an analytical review","volume":"141","author":"Spivak","year":"1977","journal-title":"Johns Hopkins Med J"},{"key":"10.1016\/j.blre.2006.01.003_bib11","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/archderm.137.10.1309","article-title":"Identification of clonal T cells in the blood of patients with systemic sclerosis: positive correlation with response to photopheresis","volume":"137","author":"French","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.blre.2006.01.003_bib12","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/blood-2002-08-2408","article-title":"Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C\/E and NKD2D killer cell receptors","volume":"101","author":"Bigouret","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1084\/jem.179.2.609","article-title":"Clonal populations of T cells in normal elderly humans: the T cell equivalent to \u201cbenign monoclonal gammapathy\u201d","volume":"179","author":"Posnett","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2006.01.003_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood.V98.1.247","article-title":"T-cell clonality of undetermined significance","volume":"98","author":"Dippel","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0037-1963(03)00133-1","article-title":"Clinical features of large granular lymphocyte leukemia","volume":"40","author":"Lamy","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2006.01.003_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0049-0172(91)90002-H","article-title":"Felty\u2019s and pseudo-Felty\u2019s syndromes","volume":"21","author":"Rosenstein","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.blre.2006.01.003_bib17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(73)90040-5","article-title":"The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases","volume":"54","author":"Gordon","year":"1973","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2006.01.003_bib18","first-page":"65","article-title":"Large granular T lymphocytes, neutropenia and polyarthropathy: an underdiagnosed syndrome?","volume":"78","author":"Snowden","year":"1991","journal-title":"Q J Med"},{"key":"10.1016\/j.blre.2006.01.003_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005792-199069020-00001","article-title":"The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations","volume":"69","author":"Campion","year":"1990","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.blre.2006.01.003_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.2005.05370.x","article-title":"Pregnancy improves neutropenia in T-cell large granular lymphocyte leukaemia","volume":"128","author":"Osuji","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.01.003_bib21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00005792-198709000-00005","article-title":"Large granular lymphocyte leukemia. Report of 38 cases and review of the literature","volume":"66","author":"Loughran","year":"1987","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.blre.2006.01.003_bib22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-4362.1981.tb02025.x","article-title":"Rheumatoid vasculitis","volume":"20","author":"Gordon","year":"1981","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.blre.2006.01.003_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.5694\/j.1326-5377.1990.tb126267.x","article-title":"Leg ulcers in rheumatoid arthritis","volume":"153","author":"Pun","year":"1990","journal-title":"Med J Aust"},{"key":"10.1016\/j.blre.2006.01.003_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9343(82)90921-4","article-title":"Liver disease in Felty\u2019s syndrome","volume":"73","author":"Thorne","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2006.01.003_bib25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0046-8177(89)90151-2","article-title":"The pathology of large granular lymphocyte leukemia","volume":"20","author":"Agnarsson","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/j.blre.2006.01.003_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/oxfordjournals.bmb.a072971","article-title":"Immunology of systemic rheumatoid disease","volume":"51","author":"Snowden","year":"1995","journal-title":"Br Med Bull"},{"key":"10.1016\/j.blre.2006.01.003_bib27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-123-3-199508010-00012","article-title":"Excitement\u2013and confusion\u2013about HLA and rheumatoid arthritis","volume":"123","author":"Harris","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2006.01.003_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.blre.2006.01.003_bib29","first-page":"585","article-title":"HLA heterozygosity contributes to susceptibility to rheumatoid arthritis","volume":"51","author":"Wordsworth","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.blre.2006.01.003_bib30","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/art.1780370909","article-title":"The large granular lymphocyte syndrome with rheumatoid arthritis. Immunogenetic evidence for a broader definition of Felty\u2019s syndrome","volume":"37","author":"Bowman","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.blre.2006.01.003_bib31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0889-857X(21)00151-4","article-title":"Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping","volume":"18","author":"Nepom","year":"1992","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.blre.2006.01.003_bib32","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/art.1780400406","article-title":"Immunogenetic similarities between patients with Felty\u2019s syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis","volume":"40","author":"Starkebaum","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.blre.2006.01.003_bib33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archinte.147.5.915","article-title":"Factors influencing the incidence of infections in Felty\u2019s syndrome","volume":"147","author":"Breedveld","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.blre.2006.01.003_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/shem.2002.31919","article-title":"Idiopathic, immune, infectious, and idiosyncratic neutropenias","volume":"39","author":"Palmblad","year":"2002","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2006.01.003_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/shem.2002.31911","article-title":"Neutropenia: causes and consequences","volume":"39","author":"Boxer","year":"2002","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2006.01.003_bib36","first-page":"267","article-title":"Severe chronic neutropenia: pathophysiology and therapy","volume":"34","author":"Welte","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2006.01.003_bib37","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.1932.02740670035010","article-title":"Effect of splenectomy in Felty\u2019s syndrome","volume":"99","author":"Hanrahn","year":"1932","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2006.01.003_bib38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.41.3.242","article-title":"Neutropenia in rheumatoid arthritis: studies on possible contributing factors","volume":"41","author":"Bucknall","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.blre.2006.01.003_bib39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archinte.138.4.597","article-title":"Splenectomy for Felty\u2019s syndrome. Clinicopathological study of 27 patients","volume":"138","author":"Laszlo","year":"1978","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.blre.2006.01.003_bib40","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.7326\/0003-4819-64-6-1265","article-title":"Splenectomy in Felty\u2019s syndrome","volume":"64","author":"Green","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2006.01.003_bib41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/ard.30.4.359","article-title":"Felty\u2019s syndrome. A clinical and pathological survey of 21 patients and their response to treatment","volume":"30","author":"Barnes","year":"1971","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.blre.2006.01.003_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7326\/0003-4819-75-3-381","article-title":"Felty\u2019s syndrome: long-term follow-up after splenectomy","volume":"75","author":"Moore","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2006.01.003_bib43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0268-960X(96)90024-7","article-title":"Treatment of the neutropenia of Felty syndrome","volume":"10","author":"Rashba","year":"1996","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2006.01.003_bib44","series-title":"Surgical Pathology of the Lymph Nodes and Related Organs","first-page":"98","article-title":"Reactive Lymphoid Hyperplasias","author":"Schnitzer","year":"1995"},{"key":"10.1016\/j.blre.2006.01.003_bib45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/imj.1961.10.4.292","article-title":"Felty\u2019s syndrome","volume":"10","author":"De Gruchy","year":"1961","journal-title":"Australas Ann Med"},{"key":"10.1016\/j.blre.2006.01.003_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00000658-196801000-00012","article-title":"The role of splenectomy in Felty\u2019s syndrome","volume":"167","author":"O\u2019Neill","year":"1968","journal-title":"Ann Surg"},{"key":"10.1016\/j.blre.2006.01.003_bib47","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/01.pas.0000160732.43909.3f","article-title":"Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review","volume":"29","author":"Osuji","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.blre.2006.01.003_bib48","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/00000658-196805000-00012","article-title":"Splenectomy for control of neutropenia in Felty\u2019s syndrome","volume":"167","author":"Sandusky","year":"1968","journal-title":"Ann Surg"},{"key":"10.1016\/j.blre.2006.01.003_bib49","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0272-2712(18)30414-1","article-title":"Practical approach to the investigation of neutropenia","volume":"13","author":"Foucar","year":"1993","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.blre.2006.01.003_bib50","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0002-9610(66)90141-3","article-title":"Hematologic disorder in Felty\u2019s syndrome. Prolonged benefits of splenectomy","volume":"112","author":"Collier","year":"1966","journal-title":"Am J Surg"},{"key":"10.1016\/j.blre.2006.01.003_bib51","series-title":"Bone Marrow Pathology","first-page":"147","article-title":"Constitutional and Reactive Myeloid Disorders","author":"Foucar","year":"2001"},{"key":"10.1016\/j.blre.2006.01.003_bib52","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2141.1979.tb03793.x","article-title":"Neutrophil marrow profiles in patients with rheumatoid arthritis and neutropenia","volume":"43","author":"Dancey","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.01.003_bib53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2141.2004.05144.x","article-title":"Bone marrow histopathology in peripheral T-cell lymphomas","volume":"127","author":"Dogan","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.01.003_bib54","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJM198311033091801","article-title":"T-lymphocyte\u2013mediated granulopoietic failure. In vitro identification of prednisone-responsive patients","volume":"309","author":"Bagby","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2006.01.003_bib55","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood.V78.5.1282.1282","article-title":"Activation signals leading to proliferation of normal and leukemic CD3+ large granular lymphocytes","volume":"78","author":"Aprile","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2141.1997.d01-2113.x","article-title":"Constitutive expression of Fas ligand in large granular lymphocyte leukaemia","volume":"97","author":"Perzova","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.01.003_bib57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0037-1963(03)00135-5","article-title":"Survival signals in leukemic large granular lymphocytes","volume":"40","author":"Epling-Burnette","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2006.01.003_bib58","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/art.20931","article-title":"Reduced p53 in peripheral blood mononuclear cells from patients with rheumatoid arthritis is associated with loss of radiation-induced apoptosis","volume":"52","author":"Maas","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.blre.2006.01.003_bib59","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1182\/blood.V94.8.2613.420k33_2613_2621","article-title":"Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL\/6-lpr\/lpr mice","volume":"94","author":"Schneider","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib60","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood.V88.6.2013.bloodjournal8862013","article-title":"Expression of Fas\/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver","volume":"88","author":"Barcena","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib61","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1634\/stemcells.20-2-174","article-title":"Human CD34+ hematopoietic stem\/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis","volume":"20","author":"Kim","year":"2002","journal-title":"Stem Cells"},{"key":"10.1016\/j.blre.2006.01.003_bib62","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1182\/blood.V86.3.883.883","article-title":"Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells","volume":"86","author":"Nagafuji","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/10428199609045713","article-title":"Fas antigen (CD95) and hematopoietic progenitor cells","volume":"24","author":"Nagafuji","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2006.01.003_bib64","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/blood.V88.8.2871.bloodjournal8882871","article-title":"In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95)","volume":"88","author":"Takenaka","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib65","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V85.11.3183.bloodjournal85113183","article-title":"Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro","volume":"85","author":"Maciejewski","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib66","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1046\/j.1365-2141.1997.562704.x","article-title":"Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells","volume":"97","author":"Sato","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.01.003_bib67","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.1995.tb05277.x","article-title":"Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia","volume":"91","author":"Maciejewski","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.01.003_bib68","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V59.1.198.198","article-title":"Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease","volume":"59","author":"Hooks","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-3083.2003.01272.x","article-title":"Aberrant T-cell receptor signalling of interferon-gamma- and tumour necrosis factor-alpha-producing cytotoxic CD8+ Vdelta1\/Vbeta16 T cells in a patient with chronic neutropenia","volume":"58","author":"Bank","year":"2003","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.blre.2006.01.003_bib70","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1182\/blood-2002-09-2898","article-title":"Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells","volume":"101","author":"Papadaki","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib71","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4161\/cc.2.5.463","article-title":"The role of apoptosis in the pathophysiology of chronic neutropenias associated with bone marrow failure","volume":"2","author":"Papadaki","year":"2003","journal-title":"Cell Cycle"},{"key":"10.1016\/j.blre.2006.01.003_bib72","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00277-003-0709-y","article-title":"Increased cell apoptosis in bone marrow trephine biopsies and immunomagnetically isolated myeloid progenitor cells in patients with chronic idiopathic neutropenia","volume":"82","author":"Koumaki","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2006.01.003_bib73","first-page":"307","article-title":"Humoral and cellular immune mechanisms of neutropenia in patients with Felty\u2019s syndrome","volume":"39","author":"Starkebaum","year":"1980","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.blre.2006.01.003_bib74","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1084\/jem.184.2.429","article-title":"Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils","volume":"184","author":"Liles","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2006.01.003_bib75","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/432764","article-title":"Turnover of neutrophils mediated by Fas ligand drives Leishmania major infection","volume":"192","author":"Ribeiro-Gomes","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2006.01.003_bib76","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood.V95.10.3219","article-title":"Chronic neutropenia mediated by fas ligand","volume":"95","author":"Liu","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib77","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nm0396-317","article-title":"Fas ligand in human serum","volume":"2","author":"Tanaka","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2006.01.003_bib78","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0037-1963(03)00136-7","article-title":"Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas\/leukemias","volume":"40","author":"Cheung","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2006.01.003_bib79","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/01.pas.0000172194.32918.5c","article-title":"CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells","volume":"29","author":"Reichard","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.blre.2006.01.003_bib80","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/364806a0","article-title":"Lethal effect of the anti-Fas antibody in mice","volume":"364","author":"Ogasawara","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.blre.2006.01.003_bib81","first-page":"238","article-title":"Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty\u2019s syndrome","volume":"96","author":"Starkebaum","year":"1980","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.blre.2006.01.003_bib82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2141.1988.tb04176.x","article-title":"Lack of evidence for the presence of neutrophil autoantibodies in the serum of patients with Felty\u2019s syndrome","volume":"68","author":"Goldschmeding","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.01.003_bib83","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2141.1986.tb02240.x","article-title":"K-cell lymphocytosis\/neutropenia syndrome: the neutropenia is not caused by autoimmunity","volume":"64","author":"van der Veen","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.01.003_bib84","doi-asserted-by":"crossref","first-page":"9234","DOI":"10.1073\/pnas.97.16.9234","article-title":"Cloning and expression of a novel human antibody-antigen pair associated with Felty\u2019s syndrome","volume":"97","author":"Ditzel","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.blre.2006.01.003_bib85","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/intimm\/11.10.1635","article-title":"Anti-elongation factor-1alpha autoantibody in adult atopic dermatitis patients","volume":"11","author":"Ohkouchi","year":"1999","journal-title":"Int Immunol"},{"key":"10.1016\/j.blre.2006.01.003_bib86","doi-asserted-by":"crossref","unstructured":"Burks EJ, Starkebaum G, Loughran Jr TP. Section III. Large granular lymphocyte leukemia and neutropenia. In: Berliner N, Horwitz M, Loughran Jr TP. Congenital and acquired neutropenia. Hematology (Am Soc Hematol Educ Program); 2004:pp. 63\u201379.","DOI":"10.1182\/asheducation-2004.1.63"},{"key":"10.1016\/j.blre.2006.01.003_bib87","first-page":"280","article-title":"Stimulation of human neutrophil chemiluminescence by soluble immune complexes and antibodies to neutrophils","volume":"98","author":"Starkebaum","year":"1981","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.blre.2006.01.003_bib88","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/art.1780251204","article-title":"Increased endothelial cell adherence, aggregation, and superoxide generation by neutrophils incubated in systemic lupus erythematosus and Felty\u2019s syndrome sera","volume":"25","author":"Hashimoto","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.blre.2006.01.003_bib89","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.45.8.696","article-title":"Immune complexes and the pathogenesis of neutropenia in Felty\u2019s syndrome","volume":"45","author":"Breedveld","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.blre.2006.01.003_bib90","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.4049\/jimmunol.161.7.3666","article-title":"Modulation of human neutrophil apoptosis by immune complexes","volume":"161","author":"Gamberale","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2006.01.003_bib91","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.leukres.2004.08.007","article-title":"Perspectives in the treatment of LGL leukemia","volume":"29","author":"Burks","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2006.01.003_bib92","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1172\/JCI2676","article-title":"Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells","volume":"102","author":"Genestier","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2006.01.003_bib93","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0162-3109(00)00189-2","article-title":"Mechanisms of action of methotrexate","volume":"47","author":"Genestier","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.blre.2006.01.003_bib94","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2249.2002.01777.x","article-title":"Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs","volume":"128","author":"Strauss","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.blre.2006.01.003_bib95","first-page":"33","article-title":"Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia","volume":"22","author":"Kothapalli","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.blre.2006.01.003_bib96","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/eji.1830150117","article-title":"Antigen-specific cytotoxic T cell and antigen-specific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3","volume":"15","author":"Spits","year":"1985","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.blre.2006.01.003_bib97","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/art.1780400405","article-title":"T cell receptor alpha-chain and beta-chain junctional region homology in clonal CD3+, CD8+ T lymphocyte expansions in Felty\u2019s syndrome","volume":"40","author":"Bowman","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.blre.2006.01.003_bib98","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.4049\/jimmunol.172.3.1960","article-title":"Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses","volume":"172","author":"O\u2019Keefe","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2006.01.003_bib99","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood.V84.7.2164.2164","article-title":"Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate","volume":"84","author":"Loughran","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib100","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/rheumatology\/37.8.908","article-title":"Methotrexate treatment in Felty\u2019s syndrome","volume":"37","author":"Wassenberg","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.blre.2006.01.003_bib101","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/anr.1780320212","article-title":"Reversal of neutropenia with methotrexate treatment in patients with Felty\u2019s syndrome. Correlation of response with neutrophil-reactive IgG","volume":"32","author":"Fiechtner","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.blre.2006.01.003_bib102","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.57.2.3","article-title":"Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis","volume":"57","author":"Cronstein","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.blre.2006.01.003_bib103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.it.2003.11.003","article-title":"Adenosine: an endogenous regulator of innate immunity","volume":"25","author":"Hasko","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.blre.2006.01.003_bib104","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00011-005-1355-8","article-title":"Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines","volume":"54","author":"Herman","year":"2005","journal-title":"Inflamm Res"},{"key":"10.1016\/j.blre.2006.01.003_bib105","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.bjp.0705054","article-title":"The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species","volume":"138","author":"Phillips","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.blre.2006.01.003_bib106","first-page":"395","article-title":"In vitro effects of methotrexate on polyamine levels in lymphocytes from rheumatoid arthritis patients","volume":"14","author":"Nesher","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.blre.2006.01.003_bib107","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/PL00000852","article-title":"Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications","volume":"58","author":"Thomas","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.blre.2006.01.003_bib108","doi-asserted-by":"crossref","first-page":"11140","DOI":"10.1073\/pnas.95.19.11140","article-title":"The natural polyamine spermine functions directly as a free radical scavenger","volume":"95","author":"Ha","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.blre.2006.01.003_bib109","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s10495-005-2947-z","article-title":"Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production","volume":"10","author":"Huang","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.blre.2006.01.003_bib110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00024382-200115040-00008","article-title":"Adenosine inhibits neutrophil vascular endothelial growth factor release and transendothelial migration via A2B receptor activation","volume":"15","author":"Wakai","year":"2001","journal-title":"Shock"},{"key":"10.1016\/j.blre.2006.01.003_bib111","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-18","article-title":"Adenosine, a potent natural suppressor of arachidonic acid release and leukotriene biosynthesis in human neutrophils","volume":"161","author":"Flamand","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.blre.2006.01.003_bib112","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1152\/jappl.1994.76.1.5","article-title":"Adenosine, an endogenous anti-inflammatory agent","volume":"76","author":"Cronstein","year":"1994","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.blre.2006.01.003_bib113","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/art.10766","article-title":"Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis","volume":"48","author":"Nesher","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.blre.2006.01.003_bib114","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1203\/00006450-197601000-00013","article-title":"Hereditary sever combined immunodeficiency and adenosine deaminase deficiency","volume":"10","author":"Ackeret","year":"1976","journal-title":"Pediatr Res"},{"key":"10.1016\/j.blre.2006.01.003_bib115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nm0596-574","article-title":"Involvement of the CD95 (APO-1\/FAS) receptor\/ligand system in drug-induced apoptosis in leukemia cells","volume":"2","author":"Friesen","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2006.01.003_bib116","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood.V92.12.4771","article-title":"Dysregulation of CD95\/CD95 ligand-apoptotic pathway in CD3 (+) large granular lymphocyte leukemia","volume":"92","author":"Lamy","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib117","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1182\/blood.V91.9.3372","article-title":"Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells","volume":"91","author":"Sood","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib118","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000040906","article-title":"Pure red cell aplasia associated to clonal CD8+ T-cell large granular lymphocytosis: dependence on cyclosporin A therapy","volume":"100","author":"Coutinho","year":"1998","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2006.01.003_bib119","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1182\/blood.V87.3.1199.bloodjournal8731199","article-title":"Rapid response to cyclosporine therapy and sustained remission in large granular lymphocyte leukemia","volume":"87","author":"Gabor","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib120","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM198601163140317","article-title":"Cyclosporine in Felty\u2019s syndrome","volume":"314","author":"Coiffier","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2006.01.003_bib121","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajh.2830360315","article-title":"Cyclosporine for the treatment of granulocytopenia in Felty\u2019s syndrome","volume":"36","author":"Canvin","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2006.01.003_bib122","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM199507203330301","article-title":"Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group","volume":"333","author":"Tugwell","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2006.01.003_bib123","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1006\/clin.1996.0140","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"80","author":"Ho","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.blre.2006.01.003_bib124","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1128\/MCB.13.8.4760","article-title":"Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location","volume":"13","author":"Bram","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.blre.2006.01.003_bib125","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood.V84.5.1620.bloodjournal8451620","article-title":"Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance","volume":"84","author":"Dhodapkar","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.01.003_bib126","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0027-5107(95)00039-L","article-title":"Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks","volume":"330","author":"Anderson","year":"1995","journal-title":"Mutat Res"},{"key":"10.1016\/j.blre.2006.01.003_bib127","first-page":"569","article-title":"[Treatment of Felty\u2019s syndrome accompanied by agranulocytosis using high-dose corticoids. 3 cases]","volume":"16","author":"Job-Deslandre","year":"1987","journal-title":"Presse Med"},{"key":"10.1016\/j.blre.2006.01.003_bib128","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/284555a0","article-title":"Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation","volume":"284","author":"Wyllie","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.blre.2006.01.003_bib129","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2249.1996.tb08306.x","article-title":"Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes","volume":"103","author":"Lanza","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.blre.2006.01.003_bib130","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.175.5.1235","article-title":"Negative regulation of interleukin 2 transcription by the glucocorticoid receptor","volume":"175","author":"Northrop","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2006.01.003_bib131","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1172\/JCI105721","article-title":"Leukokinetic studies. 13. A non-steady-state kinetic evaluation of the mechanism of cortisone-induced granulocytosis","volume":"47","author":"Bishop","year":"1968","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2006.01.003_bib132","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF01698137","article-title":"Correction of neutropenia by GM-CSF in patients with a large granular lymphocyte proliferation","volume":"65","author":"Mulder","year":"1992","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2006.01.003_bib133","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2141.1990.tb02550.x","article-title":"Agranulocytosis associated with granular lymphocyte leukaemia: improvement of peripheral blood granulocyte count with human recombinant granulocyte colony-stimulating factor (G-CSF)","volume":"74","author":"Kaneko","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.01.003_bib134","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0049-0172(99)80040-7","article-title":"Treatment of severe neutropenia due to Felty\u2019s syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor","volume":"29","author":"Hellmich","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.blre.2006.01.003_bib135","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.leu.2400607","article-title":"Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications","volume":"11","author":"Spiekermann","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2006.01.003_bib136","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-0609.1992.tb00057.x","article-title":"Differential effects of granulocyte- and granulocyte-macrophage colony-stimulating factors (G- and GM-CSF) on neutrophil adhesion in vitro and in vivo","volume":"49","author":"Yong","year":"1992","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2006.01.003_bib137","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2141.1987.tb02316.x","article-title":"Evaluation of splenectomy in large granular lymphocyte leukaemia","volume":"67","author":"Loughran","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.01.003_bib138","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jama.237.11.1116","article-title":"Improvement of rheumatoid arthritis following splenectomy for Felty syndrome","volume":"237","author":"Khan","year":"1977","journal-title":"Jama"},{"key":"10.1016\/j.blre.2006.01.003_bib139","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7326\/0003-4819-94-5-623","article-title":"Felty\u2019s syndrome: effects of splenectomy upon granulocyte count and granulocyte-associated IgG","volume":"94","author":"Blumfelder","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2006.01.003_bib140","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0002-9343(77)90422-3","article-title":"Chronic lymphoproliferative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics","volume":"62","author":"McKenna","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2006.01.003_bib141","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ajcp\/111.3.379","article-title":"Relative frequencies and sites of presentation of lymphoid neoplasms in a community hospital according to the revised European-American classification","volume":"111","author":"Siebert","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2006.01.003_bib142","unstructured":"Foucar K. Chronic Lymphoproliferative Disorders. In: K F, ed. Bone Marrow Pathology (second ed.) Chicago: ASCP Press; 2001:pp. 366\u2013405."},{"key":"10.1016\/j.blre.2006.01.003_bib143","series-title":"Neoplastic Hematopathology","first-page":"1505","article-title":"B-cell chronic lymphocytic and prolymphocytic leukemia","author":"Foucar","year":"2001"},{"key":"10.1016\/j.blre.2006.01.003_bib144","series-title":"Wintrobe\u2019s Clinical Hematology","first-page":"2428","article-title":"Hairy-Cell Leukemia","author":"Johnston","year":"1998"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X0600004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X0600004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T18:56:49Z","timestamp":1683399409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X0600004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":144,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0268960X0600004X"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2006.01.003","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}